Immune response after splenectomy.
The immune response to intravenously administered bacteriophage phiX 174 and subcutaneously administered tridecavalent pneumococcal polysaccharide vaccine was studied in 31 patients with anatomical or functional asplenia. Antibody responses to primary immunisation with phiX 174 were significantly decreased while clearance was normal. Secondary responses were quantitatively normal; however, production of antibody did not switch from IgM to IgG as seen in controls. All groups of asplenic patients accept those patients with Hodgkin's disease demonstrated significant seroconversions in response to pneumococcal polysaccharide antigens. One patient with Hodgkin's disease, treated with local irradiation only, demonstrated normal responses to pneumococcal capsular antigens. 10 of the 12 capsular antigens for which antibody was measured stimulated threefold increases in antibody in the 26 asplenic patients without Hodgkin's disease, which is similar to that observed in controls. Since the majority of cases of overwhelming postsplenectomy infection are caused by Streptococcus pneumoniae, all patients with either anatomical or functional asplenia should receive pneumococcal polysaccharide vaccine.
D000293:Adolescent; D000328:Adult; D000917:Antibody Formation; D001428:Bacterial Vaccines / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003090:Coliphages / Q000276:immunology; D006453:Hemoglobinopathies / Q000628:therapy; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D006975:Hypertension, Portal / Q000628:therapy; D007074:Immunoglobulin G / Q000096:biosynthesis*; D007153:Immunologic Deficiency Syndromes / Q000209:etiology / Q000517:prevention & control*; D008875:Middle Aged; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use; D013103:Spherocytosis, Hereditary / Q000628:therapy; D013156:Splenectomy / Q000009:adverse effects*; D013290:Streptococcal Infections / Q000209:etiology / Q000517:prevention & control; D013296:Streptococcus pneumoniae / Q000276:immunology
D001428:Bacterial Vaccines; D007074:Immunoglobulin G; D011135:Polysaccharides, Bacterial